Indications and contraindications for recombinant human erythropoietin treatment. Results in hemodialysis patients.
Samtleben
W
W
Nephrology Division, Medical Clinic I, Klinikum München-Grosshadern, Ludwig Maximilians University, Munich.
Baldamus
C A
CA
Bommer
J
J
Grützmacher
P
P
Nonnast-Daniel
B
B
Scigalla
P
P
Gurland
H J
HJ
D000740:Anemia / Q000150:complications / Q000188:drug therapy; D001166:Arteriovenous Shunt, Surgical / Q000009:adverse effects; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000139:chemically induced / Q000150:complications; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D015337:Multicenter Studies as Topic; D009369:Neoplasms / Q000150:complications; D006435:Renal Dialysis; D012640:Seizures / Q000139:chemically induced; D013922:Thrombocytosis / Q000139:chemically induced; D013927:Thrombosis / Q000139:chemically induced
D004921:Erythropoietin